No abstract available
MeSH terms
-
Animals
-
Cardiovascular Agents / pharmacology*
-
Disease Models, Animal
-
Genotype
-
Mice
-
Mice, Knockout
-
Myocardial Infarction / drug therapy*
-
Myocardial Infarction / enzymology
-
Myocardial Infarction / genetics
-
Myocardial Infarction / physiopathology
-
Myocardium / enzymology*
-
Neovascularization, Physiologic / drug effects
-
Phenotype
-
Phosphatidylinositol 3-Kinases / genetics
-
Phosphatidylinositol 3-Kinases / metabolism
-
Phosphoinositide-3 Kinase Inhibitors*
-
Protein Kinase Inhibitors / pharmacology*
-
Quinoxalines / pharmacology*
-
Thiazolidinediones / pharmacology*
-
Ventricular Function, Left / drug effects
-
Ventricular Remodeling / drug effects
Substances
-
5-quinoxalin-6-ylmethylenethiazolidine-2,4-dione
-
Cardiovascular Agents
-
Phosphoinositide-3 Kinase Inhibitors
-
Protein Kinase Inhibitors
-
Quinoxalines
-
Thiazolidinediones